There are 449 resources available
Introduction and first vote
Presenter: Natasha Leighl
Session: Does liquid biopsy have a role in monitoring adjuvant therapy?
Resources:
Slides
Webcast
Case presentation
Presenter: Elene Mariamidze
Session: Controversies in stage I NSCLC
Resources:
Slides
Webcast
Yes (PRO)
Presenter: Enriqueta Felip
Session: Does liquid biopsy have a role in monitoring adjuvant therapy?
Resources:
Slides
Webcast
When is SBRT a reasonable consideration for stage I NSCLC and should we ever consider adjuvant sytemic therapy
Presenter: Fiona McDonald
Session: Controversies in stage I NSCLC
Resources:
Slides
Webcast
No (CONTRA)
Presenter: JORDI REMON MASIP
Session: Does liquid biopsy have a role in monitoring adjuvant therapy?
Resources:
Slides
Webcast
When is surgery the only best approach for stage I NSCLC and when should we consider systemic adjuvant therapy
Presenter: Hisao Asamura
Session: Controversies in stage I NSCLC
Resources:
Slides
Webcast
Second vote and conclusions/discussion
Presenter: Natasha Leighl
Session: Does liquid biopsy have a role in monitoring adjuvant therapy?
Resources:
Slides
Webcast
Q&A and discussion
Session: Controversies in stage I NSCLC
Resources:
Webcast
Welcome and introduction
Presenter: David Planchard
Session: Clinical Care Options, LLC - TROP-2–targeted ADCs for NSCLC: Integrating a new therapeutic option
Resources:
Webcast
Welcome and introduction
Presenter: Zofia Piotrowska
Session: ESMO Colloquium supported by Eli Lilly and Company - Optimising molecular diagnosis and precision therapy in patients with advanced NSCLC harbouring rare oncogenic translocations
Resources:
Webcast